human recombin gm-csf allogen bone-marrow transplant leukaemia double-blind placebo-control trial randomis double-blind trial patient leukaemia human recombin granulocyt macrophag colony-stimul factor gm-csf placebo day allogen sibl bone-marrow transplant neutrophil count day gm-csf group placebo group signific median neutrophil count day gm-csf group /l lymphocyt count gm-csf placebo group day transplant differ incid graft-versus-host diseas evid gm-csf incid leukaem relaps gm-csf group haemoglobin concentr platelet count plasma urea creatinin bilirubin placebo group durat hospit stay patient group further studi overal effect gm-csf outcom allogen bone-marrow transplant 